Effects of Autohemotherapy on Hematologic Parameters and Morphology of Canine Oral Papillomatosis


  • Olivia Maria Moreira Borges Doutorado, Programa de Pós-graduação em Medicina Veterinária (PPGMV), Universidade Federal de Campina Grande (UFCG), Campus de Patos, PB, Brazil.
  • Cynthia Larissa Medeiros Araújo Graduação em Medicina Veterinária, Universidade Federal de Campina Grande (UFCG), Campus de Patos, PB, Brazil.
  • Gisele Cândida Ramalho Graduação em Medicina Veterinária, Universidade Federal de Campina Grande (UFCG), Campus de Patos, PB, Brazil.
  • Rosangela Maria Nunes da Silva Unidade Acadêmica de Medicina Veterinária, Universidade Federal de Campina Grande (UFCG), Campus de Patos, PB, Brazil.
  • Atticcus Tanikawa Doutorado, Programa de Pós-graduação em Medicina Veterinária (PPGMV), Universidade Federal de Campina Grande (UFCG), Campus de Patos, PB, Brazil.
  • Almir Pereira de Souza Unidade Acadêmica de Medicina Veterinária, Universidade Federal de Campina Grande (UFCG), Campus de Patos, PB, Brazil.




Background: Several treatments for oral papillomatosis in dogs, with satisfactory results, have already been described in the literature. However, there is need for further studies regarding remission time, association and exposure to drugs, side effects, cost-effectiveness and reproducibility of results. Autohemotherapy (AHT) is a therapeutic technique increasingly used in veterinary medicine that has been providing satisfactory clinical results to treat several pathologies. The procedure consists of removing blood by intravenous puncture that is immediately re-administered via intramuscular, subcutaneous, intravenous or intradermal. Although the empirical isolated use via intramuscular reached excellent results in routine medical treatment of dogs and since few studies and protocols have been described for this species, many times the treatment is based on the experience with the bovine papillomatosis. To this end, this report describes a case of canine oral papillomatosis treated with autohemotherapy (AHT), emphasizing the dosage and clinical evolution of the case.

Case: A one-year-old mongrel dog rescued from the street eight months earlier was treated. The animal was thin resulting from the small food amount ingested due to feeding difficulty, infested with ticks, had bad breath and few small warts on the lips, which, after five months, grew and multiplied, and were distributed throughout the oral cavity. The animal clinical history led to papillomatosis diagnosis, which was confirmed by cytological and histopathological exams. The AHT treatment consisted of taking 5 mL of whole blood without EDTA and immediately injecting this volume intramuscularly, every four days until the total remission of the clinical symptoms. Every four days, the papilloma fall off, and involution processes were recorded through a detailed macroscopic analysis of the warts (quantity, consistency, color and size), as well as hematological evaluations (blood count, hemoparasite screening and total plasm protein), which were performed before each AHT treatment until the complete clinical resolution of the disease (24 days).

Discussion: The dose adopted in this autohemotherapy study was clinically effective since the papillomas started to fall off after four days of therapy, with total resolution in 24 days. Therefore, it can be concluded that the 5 mL AHT injected intramuscularly every four days reduced treatment time and decreased therapeutic costs. There are few studies evaluating more accurately the hematological aspects related to the therapeutic use of autohemotherapy to treat canine oral papillomatosis, the existing reports are restricted to the initial measurement as an evaluation of the general condition of the patient and/or diagnosis of possible basal diseases. In this study, no changes were observed in the blood count during the entire therapeutic process, demonstrating that the AHT did not interfere in the red series dynamics of the treated animal. Additionally, thrombocytosis followed by thrombocytopenia exhibited a correlation with the macroscopic appearance of warts [enlargement and modified color, texture, shape and consistency]. This observation is possibly related to a platelet mobilization toward the site of action [warts], so that there was a modulation in the immune response, amplifying the inflammatory process and tissue repair, which resulted in the fall off and involution of the papillomas.


Download data is not yet available.


Bredal W.P., Thoresen S.I., Rimstad E., Aleksandersen M. & Nafstad P.H. 1996. Diagnosis and clinical course of canine oral papillomavirus infection. Journal of Small Animal Practice.

(37): 138-142.

Fenner F., Gibbs E.P.J., Murphy F.A., Rott R., Studdert M.J. & White D.O. 1993. Veterinary Virology. 2nd edn. London: Academic Press, 666p.

Fantini O., Videmont E. & Pin D. 2015. Successful treatment of florid papillomatosis in a dog using subcutaneous feline recombinant interferon-ω. Revue de Médicine Vétérinaire.

(1-2): 25-29.

Bambo O., Cardoso J.M.M., Dimande A. & Santos I.F.C. 2012. Auto-hemoterapia no tratamento da papilomatose oral canina - Relato de caso. Revista de Educação Continuada em Dermatologia e Alergologia Veterinária. 2(2): 39-43.

Lira R.N., Lempek M.R., Marinho P.V.T., Neves C.C.N. & Trombini H.R. 2012. Uso de Thuya occidentalis no tratamento da Papilomatose oral canina. PUBVET, Londrina. 6(16): 1360.

Fernandes M.C., Ribeiro M.G., Fedato F.P., Paes A.C. & Megid J. 2009. Papilomatose oral em cães: revisão da literatura e estudo de doze casos. Semina: Ciências Agrárias, Londrina. 30(1): 215-224.

Cesarino M., Ávila D.F., Fernandes C.C., Silva C.B., Scherer D.L., Dias T.A., Mendonça C.S. & Castro J.R. 2008.

Efeito da autohemoterapia associada com clorabutanol no tratamento da papilomatose oral em cão (Canis familiaris).

Arquivo Brasileiro de Medicina Veterinária e Zootecnia.

(46): 145-148.

Borges O.M.M., Silva R.M.N., Mendes R.S. & Souza A.P. 2014. Auto-hemoterapia, uma nova ou antiga alternativa terapêutica? Revisão de literatura. Medvep - Revista Científica de Medicina Veterinária - Pequenos Animais e Animais de Estimação.

(39): 32-40.

Yaci B.B., Ural K., Öcal N. & Haydardedeolu A.E. 2008. Azithromycin therapy of papillomatosis in dogs: a prospective,

randomized, double-blinded, placebo-controlled clinical Trial. The Authors. Journal compilation. (19): 194-198.

Kaneko J.J., Harvey J.W. & Bruss M.L. 2008. Clinical Biochemistry of Domestic Animals. 6.ed. Rio de Janeiro:

Elsevier, 905p.

Calvert C.A. 2003. Canine viral papillomatosis. In: Greene E.C. (Ed). Infectious diseases of the dog and cat. 3rd edn. Philadelphia: W.B. Saunders Company, pp.288-290.

Wall M. & Calvert C.A. 2006. Canine viral papillomatosis. In: Greene C.E. (Ed). Infectious disease in the dog and cat. 3rd edn. Philadelphia: W.B. Saunders, pp.73-78.

Silva B.J.A., Freire I.M.A., Silva W.B. & Amarante E.E.V.G. 2010. Avaliação das alterações hematológicas nas infecções por helmintos e protozoários em cães [Canis lupus familiaris, Linnaeus, 1758]. Neotropical Helminthology. 4(1): 37-48.

Santos F, Coppede J.S. Pereira A.L., Oliveira L.P., Roberto P.G., Benedetti R.B., Zucoloto L.B., Lucas F., Sobreira L. & Marins M. 2009. Molecular evaluation of the incidence of Ehrlichia canis, Anaplasma platys and Babesia spp. in dogs from Ribeirão Preto, Brazil. The Veterinary Journal. 179(1): 145-148.

Oliveira N.F., Melo M.M. & Lago L.A. 2002. Papilomatose. Arquivo Brasileiro de Medicina Veterinária e Zootecnia.

(74): 14-15.

Tilley L.P. & Francis W.K. 2015. Consulta Veterinária em 5 min. 5.ed. São Paulo: Manole, 1560p.

Raskin R.E. & Meyer D.J. 2011. Citologia clínica de cães e gatos. 2.ed. Rio de Janeiro: Elsevier, 472p.

Moura L. 2006. Auto-hemoterapia: conversa com o Dr. Luiz Moura. Disponível em:

auto-hemoterapia-dvd.htm.>. [Accessed online in December 2016].

Klemparskaya N.N., Shalnova G.A., Ulanova A.M., Kuzmina T.D. & Chuhorv A.V. 1986. Immunomodulating effect of autohaemotherapy [a literature review]. Journal Hygiene, Epidemiology, Microbiology and Immunology. 30(3): 331-336.

Mettenleiter M.W. 1936. Autohemotransfusion in preventing postoperative lung complications. American Journal of Surgery. 32(2): 321-323.

Teixeira J. 1940. Complicações Pulmonares Pós-Operatórias Autohemotransfusão. Revista Brasileira de cirurgia. 2(3): 213-230.

Semple J.W., Italiano J.E.J. & Freedman J. 2011. Platelets and the immune continuum. Nature Reviews Immunology.

(4): 264-74.

Lane E.P. & Tübbesing U. 2007. Multiple cutaneous inverted papillomas in a dog. Journal of the South African Veterinary Association. 78(4): 221-223.



How to Cite

Borges, O. M. M., Araújo, C. L. M., Ramalho, G. C., da Silva, R. M. N., Tanikawa, A., & de Souza, A. P. (2017). Effects of Autohemotherapy on Hematologic Parameters and Morphology of Canine Oral Papillomatosis. Acta Scientiae Veterinariae, 45, 6. https://doi.org/10.22456/1679-9216.85910

Most read articles by the same author(s)